LU87471A1 - Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer - Google Patents

Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer Download PDF

Info

Publication number
LU87471A1
LU87471A1 LU87471A LU87471A LU87471A1 LU 87471 A1 LU87471 A1 LU 87471A1 LU 87471 A LU87471 A LU 87471A LU 87471 A LU87471 A LU 87471A LU 87471 A1 LU87471 A1 LU 87471A1
Authority
LU
Luxembourg
Prior art keywords
acid
fatty acids
active components
lysine
antiviral
Prior art date
Application number
LU87471A
Other languages
English (en)
French (fr)
Inventor
Peter Literati Nagy
Maria Boros
Jenoe Szilbereky
Istvan Racz
Gyoengyver Soos
Miklos Koller
Alan Pinter
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of LU87471A1 publication Critical patent/LU87471A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU87471A 1988-03-09 1989-03-09 Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer LU87471A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU881132A HU209973B (en) 1988-03-09 1988-03-09 Process for production of antiviral and immunstimular pharmaceutical composition

Publications (1)

Publication Number Publication Date
LU87471A1 true LU87471A1 (fr) 1990-10-02

Family

ID=10952974

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87471A LU87471A1 (fr) 1988-03-09 1989-03-09 Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer

Country Status (14)

Country Link
JP (1) JPH01316316A (ko)
KR (1) KR890014103A (ko)
BE (1) BE1002890A3 (ko)
CA (1) CA1334576C (ko)
CH (1) CH678918A5 (ko)
DE (1) DE3907649C2 (ko)
FI (1) FI94591C (ko)
FR (1) FR2628324B1 (ko)
GB (1) GB2216418B (ko)
HU (1) HU209973B (ko)
IT (1) IT1229562B (ko)
LU (1) LU87471A1 (ko)
NL (1) NL8900574A (ko)
SE (1) SE8900828L (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
EP0690709A1 (en) * 1993-03-26 1996-01-10 DINU, Constantin Romulus Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
GB9318611D0 (en) * 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5767156A (en) * 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
WO1996030381A1 (en) * 1995-03-28 1996-10-03 Novo Nordisk A/S Immunosuppressive agents
HU227588B1 (hu) 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
EP2219639A1 (en) * 2007-12-17 2010-08-25 University of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3463310B1 (en) * 2016-05-25 2023-07-05 Evonik Operations GmbH Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
AU2018317802B2 (en) 2017-08-15 2024-04-04 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
BR112022002129A2 (pt) 2019-08-08 2022-04-19 Evonik Operations Gmbh Processo a jusante para a produção de sais de ácidos graxos poli-insaturados
US20220287345A1 (en) 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256162A (en) * 1968-08-16 1971-12-08 Braun Fa B Improvements in and relating to liquid products for intravenous administration
FR2215212B1 (ko) * 1973-01-18 1976-03-05 Seperic Ch
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
GB2118437B (en) * 1982-03-01 1984-12-12 Efamol Ltd Composition for treating alcoholism
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
DE3229956A1 (de) * 1982-08-12 1984-02-16 Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf Arzneimittel mit cytostatischer wirkung
DE3514328C1 (de) * 1985-04-19 1986-09-11 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg Verwendung von L-Ornithin bei der selektiven Hemmung von cytotoxischen T-Lymphozyten-Effektorzellen
WO1988001861A1 (en) * 1986-09-17 1988-03-24 Baxter Travenol Laboratories, Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases
AU1489688A (en) * 1987-02-20 1988-09-14 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
FI94591B (fi) 1995-06-30
FR2628324B1 (fr) 1994-05-27
KR890014103A (ko) 1989-10-21
HU209973B (en) 1995-01-30
FI94591C (fi) 1995-10-10
SE8900828L (sv) 1989-09-10
JPH01316316A (ja) 1989-12-21
FI891145A0 (fi) 1989-03-09
DE3907649C2 (de) 1996-07-11
BE1002890A3 (fr) 1991-07-16
IT8919704A0 (it) 1989-03-09
DE3907649A1 (de) 1989-09-28
GB2216418B (en) 1991-12-11
FR2628324A1 (fr) 1989-09-15
GB2216418A (en) 1989-10-11
IT1229562B (it) 1991-09-04
CH678918A5 (ko) 1991-11-29
HUT60432A (en) 1992-09-28
NL8900574A (nl) 1989-10-02
GB8905385D0 (en) 1989-04-19
SE8900828D0 (sv) 1989-03-09
FI891145A (fi) 1989-09-10
CA1334576C (en) 1995-02-28

Similar Documents

Publication Publication Date Title
LU87471A1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
BE1003663A3 (fr) Nouveaux sels antiviraux, compositions pharmaceutiques les contenant et procede pour les preparer.
FR2590170A1 (fr) Agents therapeutiques a base de sel d'acyloxyalcanoylcholine, apportant une amelioration dans le traitement de la demence
FR2630648A1 (ko)
JP4976307B2 (ja) 新規な抗ウイルス性および免疫刺激性の医薬組成物
NL8200022A (nl) Farmaceutische samenstelling, die gamma-butyrobetaine bevat, voor de behandeling van door l-carnitine gebrek teweeggebrachte syndromen.
FR2626472A1 (fr) Utilisation des proteines du lait pour la fabrication d'un medicament antiviral
EP1165089A1 (fr) Utilisation de la tianeptine pour l'obtention de medicaments destines au traitement des pathologies de la neurodegenerescence
FR2747307A1 (fr) Application a titre de medicament des ceramides et compositions notamment pharmaceutiques les renfermant
EP0470144B1 (fr) D-acide aspartique beta-hydroxamate pour le traitement des infections virales et des tumeurs
US4845130A (en) Antihyperlipidemic amines
RU2022561C1 (ru) Противоишемическое средство
EP0295166A1 (fr) Compositions pharmaceutiques contenant un mélange de sels de cétoacides et d'amino-acides
Audit et al. Possible involvement of an acylation mechanism in thalidomide‐induced teratogenesis of the newt (Pleurodeles waltl.)
JPS6011418A (ja) 抗炎症剤
EP0602026A1 (fr) Nouveau derive organique d'un metal a structure phospholipidique, utilisation de ce derive comme agent biomediateur, procede d'isolement de ce derive et compositions pharmaceutiques le contenant
FR2721315A1 (fr) Dérivés de l'acide guanylique et applications comme médicaments.
FR2682597A1 (fr) Trimethyl-6,10,14-pentadecatriene-5-9,13-one-2-(e,e) pour son application en tant que substance therapeutiquement active.
JPH0491025A (ja) 糖尿病性合併症治療剤
FR2721826A1 (fr) Utilisation de composes 2, 6-di-t-butylphenols substitues en position 4 dans le traitement et la prevention du sida